SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREPTOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS : I. METHOD OF

T M Rivers1

  • 1Hospital of The Rockefeller Institute for Medical Research.

Insights

Researchers found that intradermal injections of hemolytic streptococcus in rabbits caused skin lesions. A protective serum was developed from rabbits repeatedly inoculated with the bacteria, demonstrating its efficacy against streptococcal skin injury.

Area of Science:

  • Microbiology
  • Immunology
  • Dermatology

Background:

  • Hemolytic streptococcus is a pathogen associated with human erysipelas.
  • The ability of this bacterium to induce skin lesions and the potential for developing protective immunity were not well understood.

Purpose of the Study:

  • To investigate the capacity of hemolytic streptococcus to produce skin lesions in rabbits.
  • To develop and test a serum for protective effects against streptococcal skin injury.

Main Methods:

  • Cultures of hemolytic streptococcus were injected intradermally into rabbits to induce lesions.
  • Serum was obtained from rabbits receiving repeated intracutaneous inoculations of the organism.
  • The protective capacity of the procured serum was assessed by intradermal injections of streptococcus-serum mixtures in normal rabbits.

Main Results:

  • Intradermal inoculation of hemolytic streptococcus reliably produced phlegmonous and erysipelas-like skin lesions in rabbits.
  • Intravenous or intraperitoneal administration of large bacterial doses did not result in fatalities.
  • Serum from inoculated rabbits demonstrated a protective effect against streptococcal skin injury, unlike normal serum.

Conclusions:

  • Hemolytic streptococcus can induce significant skin lesions via intradermal inoculation in rabbits.
  • A protective serum against streptococcal skin damage can be generated through repeated intracutaneous immunization.
  • This study provides a method for testing sera for protective substances against streptococcus.

Related Concept Videos